Shire Pharmaceuticals Ireland Limited Takeda GmbH Takeda Pharmaceuticals International AG Ireland Branch
PolandAll medications by this manufacturer
-
Elvanse
Form: capsules, hard
Active substance Dosage lisdexamfetamine mesylate 30 mg ATC: N06BA12
-
Elvanse
Form: capsules, hard
Active substance Dosage lisdexamfetamine mesylate 50 mg ATC: N06BA12
-
Elvanse
Form: capsules, hard
Active substance Dosage lisdexamfetamine mesylate 70 mg ATC: N06BA12
-
Elvanse
Form: capsules, hard
Active substance Dosage lisdexamfetamine mesylate 20 mg ATC: N06BA12
-
Elvanse
Form: capsules, hard
Active substance Dosage lisdexamfetamine mesylate 40 mg ATC: N06BA12
-
Elvanse
Form: capsules, hard
Active substance Dosage lisdexamfetamine mesylate 60 mg ATC: N06BA12